Person who experienced the adverse event (patient)
Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4330790 | 4106473 | F | 1 | 4330790-8 | 20040316 | 20040331 | EXP | USA040259864 | ELI LILLY AND COMPANY | 81 | YR | F | N | 20040324 | MD |
Drug(s) used by person
Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
---|---|---|---|---|---|---|---|---|---|---|---|
4330790 | 1004757088 | PS | FORTEO | 1 | 20 UG/1 DAY | 21318 |
Indications of drugs used
Event ID | DRUG SEQ | INDI PT |
---|---|---|
4330790 | 1004757088 | OSTEOPOROSIS |
Outcome of event
Event ID | OUTC COD |
---|---|
4330790 | OT |
Reactions reported
Event ID | PT |
---|---|
4330790 | ANAEMIA |
4330790 | BONE MARROW DISORDER |
4330790 | MYELODYSPLASTIC SYNDROME |
4330790 | MYELOFIBROSIS |
Reporting Sources (this data is often not reported and may therefore be missing here)
Event ID | RPSR COD |
---|---|
4330790 | HP |
Therapies reported
Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|
4330790 | 1004757088 | 20030201 |